Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Neil Smith

Showing results (41-50 of 108) with videos related to

Pageof 11
Sort By:
Molecular Genetics and Metabolism|March 30, 2019
Phase I clinical evaluation of CNSA-001 (sepiapterin), a novel pharmacological treatment for phenylketonuria and tetrahydrobiopterin deficiencies, in healthy volunteersNeil Smith, Nicola Longo, Keith Levert, et al.
Behavioural and Cognitive Psychotherapy|June 29, 2013
Sleep related beliefs and their association with alcohol relapse following residential alcohol detoxification treatmentNeil Smith, Robert Hill, Jane Marshall, et al.
Journal of Affective Disorders|July 26, 2003
Response style, interpersonal difficulties and social functioning in major depressive disorderDominic Lam, Nikki Schuck, Neil Smith, et al.
Genetic Engineering|November 6, 2002
Gene silencing--principles and applicationCathryn Horser, David Abbott, Varsha Wesley, et al.
Molecular Genetics and Metabolism Reports|August 28, 2019
Exploratory study of the effect of one week of orally administered CNSA-001 (sepiapterin) on CNS levels of tetrahydrobiopterin, dihydrobiopterin and monoamine neurotransmitter metabolites in healthy volunteersNeil Smith, Nicola Longo, Keith Levert, et al.
Pharmaceuticals (Basel, Switzerland)|November 27, 2024
A Phase 1 Study to Assess the Pharmacokinetics, Food Effect, Safety, and Tolerability of Sepiapterin in Healthy Japanese and Non-Japanese ParticipantsLan Gao, Diksha Kaushik, Kimberly Ingalls, et al.
Metabolism: Clinical and Experimental|January 1, 2022
PTC923 (sepiapterin) lowers elevated blood phenylalanine in subjects with phenylketonuria: a phase 2 randomized, multi-center, three-period crossover, open-label, active controlled, all-comers studyDrago Bratkovic, Lali Margvelashvili, Michel C Tchan, et al.
Journal of Behavioral Addictions|June 28, 2016
Gender Differences in Treatment-Seeking British Pathological GamblersSilvia Ronzitti, Vittorio Lutri, Neil Smith, et al.
American Journal of Obstetrics and Gynecology|October 18, 2015
Alterations to the maternal circulating proteome after preeclampsiaMalia Su-Qin Murphy, Egle Bytautiene, George Saade, et al.
Archives of Disease in Childhood|September 21, 2010
Parenteral nutrition for neonates and children: a mixed bagDavid G Mason, John W L Puntis, Kenny McCormick, et al.
Pageof 11

Showing results (41-50 of 108) with videos related to

Sort By:
Pageof 11
Molecular Genetics and Metabolism|March 30, 2019
Phase I clinical evaluation of CNSA-001 (sepiapterin), a novel pharmacological treatment for phenylketonuria and tetrahydrobiopterin deficiencies, in healthy volunteersNeil Smith, Nicola Longo, Keith Levert, et al.
Behavioural and Cognitive Psychotherapy|June 29, 2013
Sleep related beliefs and their association with alcohol relapse following residential alcohol detoxification treatmentNeil Smith, Robert Hill, Jane Marshall, et al.
Journal of Affective Disorders|July 26, 2003
Response style, interpersonal difficulties and social functioning in major depressive disorderDominic Lam, Nikki Schuck, Neil Smith, et al.
Genetic Engineering|November 6, 2002
Gene silencing--principles and applicationCathryn Horser, David Abbott, Varsha Wesley, et al.
Molecular Genetics and Metabolism Reports|August 28, 2019
Exploratory study of the effect of one week of orally administered CNSA-001 (sepiapterin) on CNS levels of tetrahydrobiopterin, dihydrobiopterin and monoamine neurotransmitter metabolites in healthy volunteersNeil Smith, Nicola Longo, Keith Levert, et al.
Pharmaceuticals (Basel, Switzerland)|November 27, 2024
A Phase 1 Study to Assess the Pharmacokinetics, Food Effect, Safety, and Tolerability of Sepiapterin in Healthy Japanese and Non-Japanese ParticipantsLan Gao, Diksha Kaushik, Kimberly Ingalls, et al.
Metabolism: Clinical and Experimental|January 1, 2022
PTC923 (sepiapterin) lowers elevated blood phenylalanine in subjects with phenylketonuria: a phase 2 randomized, multi-center, three-period crossover, open-label, active controlled, all-comers studyDrago Bratkovic, Lali Margvelashvili, Michel C Tchan, et al.
Journal of Behavioral Addictions|June 28, 2016
Gender Differences in Treatment-Seeking British Pathological GamblersSilvia Ronzitti, Vittorio Lutri, Neil Smith, et al.
American Journal of Obstetrics and Gynecology|October 18, 2015
Alterations to the maternal circulating proteome after preeclampsiaMalia Su-Qin Murphy, Egle Bytautiene, George Saade, et al.
Archives of Disease in Childhood|September 21, 2010
Parenteral nutrition for neonates and children: a mixed bagDavid G Mason, John W L Puntis, Kenny McCormick, et al.
Pageof 11